Safety Study Extension of Iloprost Power 15 in Pulmonary Arterial Hypertension

PHASE3CompletedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

September 30, 2008

Primary Completion Date

June 30, 2010

Study Completion Date

June 30, 2010

Conditions
Pulmonary Arterial Hypertension
Interventions
DRUG

iloprost

Iloprost 5 mcg delivered by I-neb(R) adaptive aerosol delivery (AAD)(R) System power disc-6 administered 6 to 9 times per day for 12 weeks. If patient enters open label follow-up period, iloprost 5 mcg delivered by I-neb(R)AAD(R) System power disc-15 administered 6 to 9 times per day until the end of study.

DRUG

iloprost

Iloprost 5 mcg delivered by I-neb(R)AAD(R) System power disc-15 administered 6 to 9 times per day for 12 weeks. If patient enters open label follow-up period, iloprost 5 mcg delivered by I-neb(R)AAD(R) System power disc-15 administered 6 to 9 times per day until the end of study.

Trial Locations (34)

8036

LHK Universitatsklinikum Graz, Graz

11501

Winthrop University Hospital, Mineola

15212

Allegheny General Hospital, Pittsburgh

19140

Temple University Hospital, Philadelphia

19713

Lung Health & Sleep Enhancement Center, LLC, Newark

21201

University of Maryland Medical Center, Baltimore

22908

University of Virginia, Charlottesville

23507

Sentara Hospitals T/A Sentara Cardiovascular Research Institute, Norfolk

29072

Lexington Pulmonary & Critical Care, Lexington

30033

Atlanta Institute for Medical Research, Decatur

30342

Pulmonary & Critical Care of Atlanta, Atlanta

32610

University of Florida, Gainesville

40202

Kentuckiana Pulmonary Associates, Louisville

43221

The Ohio State University Medical Center, Columbus

45219

The Lindner Clinical Trial Center, Cincinnati

52242

University of Iowa Hospitals and Clinics, Iowa City

52245

Mercy Hospital, Iowa City

53215

Comprehensive Cardiovascular Care LLP, Milwaukee

53792

UW Hospital & Clinics, Madison

68198

University of Nebraska Medical Center, Omaha

70112

LSU Health Sciences Center, New Orleans

77030

University of Texas Medical School, Houston

84003

Central Utah Clinic, P.C., American Fork

84157

Intermountain Medical Center, Murray

90502

Liu Center for Pulmonary Hypertension - LA Biomedical Research Institute at Harbor-UCLA, Torrance

92037

UCSD Medical Center, La Jolla

95817

UC Davis Medical Center, Sacramento

97210

Legacy Health System, Portland

99204

Spokane Respiratory Consultants, Spokane

07112

Newark Beth Israel Medical Center, Newark

27599-7020

University of North Carolina, Chapel Hill

02903

Rhode Island Hospital, Providence

75390-8550

UT Southwestern Medical Center Heart Lung and Vacular Center, Dallas

D-01307

Universitatsklinikum Carl-Gustav-Carus, Dresden

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Actelion

INDUSTRY

NCT00709098 - Safety Study Extension of Iloprost Power 15 in Pulmonary Arterial Hypertension | Biotech Hunter | Biotech Hunter